Showing 1031-1040 of 2028 results for "".
- Icon Skincare Launches Prestige Brand Focused on Simplicity, Confidence, and Ritualhttps://modernaesthetics.com/news/icon-skincare-launches-prestige-brand-focused-on-simplicity-confidence-and-ritual/2487304/Innovative Skincare, the company behind the global cosmeceutical brand iS Clinical, has announced the launch of Icon Skincare, a new prestige skincare line designed to simplify routines while emphasizing skin health, confidence, and daily ritual. Founded by Bryan Johns and Alec Call, Icon
- Case Series Evaluates Anatomy-Based Thread Lifting for Nasolabial Fold Rejuvenationhttps://modernaesthetics.com/news/case-series-evaluates-anatomy-based-thread-lifting-for-nasolabial-fold-rejuvenation/2487262/A personalized, anatomy-guided thread lifting strategy using multiple vector patterns demonstrated favorable aesthetic outcomes for nasolabial fold (NLF) correction in a small retrospective case series published in JPRAS Open. In the study, investigators evaluated 22 patients trea
- Imaging Study Explores Tissue Repair Dynamics After UltraClear Laser Therapyhttps://modernaesthetics.com/news/imaging-study-explores-tissue-repair-dynamics-after-ultraclear-laser-therapy/2487167/Serial line-field confocal optical coherence tomography (LC-OCT) imaging may provide a noninvasive method for visualizing tissue repair following laser-coring procedures, according to findings published in Lasers in Surgery and Medicine.1 In the technical demonstration
- SCALE 2026: Ipsen Reports Phase 2 Corabotase Data in Glabellar Lineshttps://modernaesthetics.com/news/scale-2026-ipsen-reports-phase-2-corabotase-data-in-glabellar-lines/2487141/Ipsen presented late-breaking Phase 2 data for corabotase, its investigational recombinant neuroinhibitor, in moderate-to-severe glabellar lines at the 2026 SCALE Symposium in Nashville, Tennessee. The study included 183 patients. At week 4, 66% of patients treated with corabotase 50 ng ac
- Direct Brow Lift Shows Durable Results and High Satisfaction in Prospective Studyhttps://modernaesthetics.com/news/direct-brow-lift-shows-durable-results-and-high-satisfaction-in-prospective-study/2487140/A prospective study published online ahead of print in Aesthetic Plastic Surgery evaluated the long-term efficacy, scar-related outcomes, and patient satisfaction associated with the direct brow lift using the Castanares tec
- LaserAway Marks 20 Years with Continued National Expansionhttps://modernaesthetics.com/news/laseraway-marks-20-years-with-continued-national-expansion/2487069/LaserAway is celebrating its 20th anniversary alongside continued national expansion and recent recognition within the aesthetics industry. The company, which specializes in aesthetic dermatology services, announced that it now operates more than 215 clinics across the United States. The c
- ASLMS 2026: Lumenis Reports New Laser Findings in Scalp Treatment, Rhinophyma, Photodamaged Skinhttps://modernaesthetics.com/news/aslms-2026-lumenis-reports-new-laser-findings-in-scalp-treatment-rhinophyma-photodamaged-skin/2487036/Lumenis Be Ltd. presented new clinical data on several aesthetic devices at the 45th Annual American Society for Laser Medicine and Surgery Conference, held May 7-9, 2026, in Savannah, Georgia, according to a company announcement. The presentations included data on FoLix, a 1565-nm nonabla
- Rapalogix Health Launches Re-Q Pro-Longevity Serum with Focus on Cellular Skin Aginghttps://modernaesthetics.com/news/rapalogix-health-launches-re-q-pro-longevity-serum-with-focus-on-cellular-skin-aging/2487003/Rapalogix Health has introduced its new Re-Q Pro-Longevity Face Serum during a virtual launch event on Thursday, May 7, featuring co-Founder and board-certified dermatologist Doris Day, MD, and co-Founder and CEO Rahul Mehta. The webinar focused on the science behind the product and the company’s
- Review Examines Dermatologic Effects of Rapid Weight Losshttps://modernaesthetics.com/news/review-examines-dermatologic-effects-of-rapid-weight-loss/2486984/Rapid weight loss associated with bariatric surgery, glucagon-like peptide-1 receptor agonists (GLP-1 RA), and intensive lifestyle interventions may contribute to dermatologic and structural changes that extend beyond reduced body size, according to a narrative rev
- iS Clinical Launches New Eye Gel Highlighting Multimodal Periocular Carehttps://modernaesthetics.com/news/is-clinical-launches-new-eye-gel-highlighting-multimodal-periocular-care/2486957/A new topical formulation targeting the periocular region is entering the aesthetics market, with iS Clinical announcing the launch of GeneXC Firming Eye Gel. The product is designed to address common concerns such as laxity, uneven tone, and dehydration in the delicate eye area. The formu